Martha M. Faraday

Papers

Total Citations

1,839

H-Index

About

Martha M. Faraday has made transformative contributions to urologic oncology, particularly in the evidence-based management of small renal masses. As lead author of the landmark "Guideline for Management of the Clinical T1 Renal Mass" (2009), which has garnered over 1,800 citations, she helped establish the modern framework for treating early-stage kidney cancer. Her work systematically evaluated the comparative effectiveness of partial nephrectomy, radical nephrectomy, and ablative therapies, providing clinicians with clear, data-driven recommendations that have shaped surgical decision-making worldwide. Beyond this seminal guideline, Faraday's research portfolio spans clinical trial methodology, systematic reviews, and outcomes research in urology. Her contributions have been instrumental in advancing patient-centered care by emphasizing renal function preservation and minimizing overtreatment. Through rigorous evidence synthesis and guideline development, she has directly influenced how urologists approach the clinical T1 renal mass—a common and clinically challenging presentation. Faraday's impact is measured not only in citations but in the countless patients who have benefited from more precise, less invasive treatment strategies. Her work remains a cornerstone for researchers and clinicians navigating the complexities of kidney cancer management.